Extracellular domain, hinge, and transmembrane determinants affecting surface CD4 expression of a novel anti-HIV chimeric antigen receptor (CAR) construct
Open Access
- 12 August 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (8) , e0293990
Abstract
Chimeric antigen receptor (CAR)-T cells have demonstrated clinical potential, but current receptors still need improvements to be successful against chronic HIV infection. In this study, we address some requirements of CAR motifs for strong surface expression of a novel anti-HIV CAR by evaluating important elements in the extracellular, hinge, and transmembrane (TM) domains. When combining a truncated CD4 extracellular domain and CD8α hinge/TM, the novel CAR did not express extracellularly but was detectable intracellularly. By shortening the CD8α hinge, CD4-CAR surface expression was partially recovered and addition of the LYC motif at the end of the CD8α TM fully recovered both intracellular and extracellular CAR expression. Mutation of LYC to TTA or TTC showed severe abrogation of CAR expression by flow cytometry and confocal microscopy. Additionally, we determined that CD4-CAR surface expression could be maximized by the removal of FQKAS motif at the junction of the extracellular domain and the hinge region. CD4-CAR surface expression also resulted in cytotoxic CAR T cell killing of HIV Env+ target cells. In this study, we identified elements that are crucial for optimal CAR surface expression, highlighting the need for structural analysis studies to establish fundamental guidelines of CAR designs.Keywords
Funding Information
- Office of Research Infrastructure Programs (P51 OD011104)
- Division of Intramural Research (AL110158)
- Division of Intramural Research (AI145642)
- Division of Intramural Research (AI102693)
- Division of Intramural Research (F30AI150452)
- Tulane University (Pilot Study)
This publication has 77 references indexed in Scilit:
- Recent Advances in CAR-T Cell Therapy for Non-Hodgkin LymphomaClinical Lymphoma Myeloma and Leukemia, 2019
- Optimizing intracellular signaling domains for CAR NK cells in HIV immunotherapy: a comprehensive reviewDrug Discovery Today, 2019
- Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and managementBlood Reviews, 2019
- Memory and CAR‐NK cell‐based novel approaches for HIV vaccination and eradicationJournal of Cellular Physiology, 2019
- Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T CellsImmunity, 2016
- Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backboneCancer Immunology, Immunotherapy, 2015
- Ectopic expression of anti-HIV-1 shRNAs protects CD8+ T cells modified with CD4ζ CAR from HIV-1 infection and alleviates impairment of cell proliferationBiochemical and Biophysical Research Communications, 2015
- A Phase II Randomized Study of HIV-Specific T-Cell Gene Therapy in Subjects with Undetectable Plasma Viremia on Combination Antiretroviral TherapyMolecular Therapy, 2002
- Two Lyt-2 polypeptides arise from a single gene by alternative splicing patterns of mRNACell, 1985
- The mouse antigen complex—I. Mode of association of the subunits with the membraneMolecular Immunology, 1984